Related references
Note: Only part of the references are listed.Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
Chakshu Sharma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-κB dependent AP-1-mediated ICAM-1 expression in breast cancer cells
Mansoor Ahmed et al.
MOLECULAR CANCER (2010)
Tumor-Derived Pancreatic Stellate Cells Promote Pancreatic Cancer Cell Invasion Through Release of Thrombospondin-2
Buckminster Farrow et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells
Jiasen Cheng et al.
CANCER RESEARCH (2007)
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
A Kolb et al.
CANCER BIOLOGY & THERAPY (2005)
Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer
S Schneider et al.
CLINICAL CANCER RESEARCH (2004)
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
HW Pan et al.
CANCER (2003)
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology
CA Iacobuzio-Donahue et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
